tiprankstipranks
Trending News
More News >
ALK-abello A/S Class B (AKBLF)
OTHER OTC:AKBLF

Compare ALK-abello (AKBLF) vs. Competitors

Compare
14 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
ALK-abello
$36.12
$7.99B
48.97
77.96%
0 Buy
0 Hold
0 Sell
Moderate Buy
Dynavax
$15.41
$1.81B
-40.35
22.11%
2 Buy
1 Hold
0 Sell
Moderate Buy
Inovio Pharmaceuticals
$1.61
$110.61M
-0.62
-22.97%
2 Buy
1 Hold
0 Sell
Moderate Buy
Aclaris Therapeutics
$2.68
$290.37M
-1.94
8.94%
5 Buy
0 Hold
0 Sell
Strong Buy
Emergent Biosolutions
$13.36
$701.67M
10.32
32.41%
1 Buy
0 Hold
0 Sell
Moderate Buy
Novartis
$141.46
$271.96B
19.17
41.15%
1 Buy
4 Hold
1 Sell
Hold
Bristol-Myers Squibb
$55.90
$113.80B
18.86
-1.60%
8 Buy
11 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AKBLF
ALK-abello
36.13
15.91
78.66%
DVAX
Dynavax
15.41
2.93
23.48%
INO
Inovio Pharmaceuticals
1.61
-0.29
-15.26%
ACRS
Aclaris Therapeutics
2.68
0.20
8.06%
EBS
Emergent Biosolutions
13.36
3.95
41.98%
NVS
Novartis
141.46
45.11
46.82%
BMY
Bristol-Myers Squibb
55.90
3.20
6.07%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts